Request Trial

Pharma news

Reset all filters
Geography
Company
Refine search
J&J pledges not to enforce TB patents in certain countries
Africa
J&J pledges not to enforce TB patents in certain countries
Non-profit hails move but urges other big pharma companies to follow suit | To avoid litigation, manufacturers must ensure generic versions are of good quality, medically acceptable, and are used only in the selected low-and middle-income countries.   3 October 2023
Eli Lilly walks away from $176.5m damages after judge overturns Teva win
Pharma
Eli Lilly walks away from $176.5m damages after judge overturns Teva win
Teva’s patents protecting migraine drug ruled invalid | Lilly’s motion for a new trial denied | ‘The court does not reach this decision nor overturn a jury verdict lightly’ says Judge Alison Burroughs.   28 September 2023
Why Fed Circ's 'Cellect' decision cannot be ignored
Pharma
Why Fed Circ's 'Cellect' decision cannot be ignored
A Federal Circuit decision provides lessons on why inaction over patent terms may risk incurable invalidation of important patents, writes Vincent Shier of Haynes Boone.   28 September 2023
Pharma
Dykema adds senior counsel to IP team
ANDA litigation expert brings chemical, biotech, and pharmaceutical experience to the firm.   26 September 2023
Pharma
‘A huge shame’: UPC denies access to pleadings and evidence in Sanofi v Amgen
An updated UPC rule requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence | The wish from a natural person to form an opinion on the validity of a patent deemed insufficient reason for access | First decision marks latest twist in Amgen v Sanofi showdown.   26 September 2023
Americas
Roche unit wins Fed Circ clash over blood clot treatment
Long-running legal dispute tackles questions of enablement and ‘undue experimentation’ | Federal Circuit says it is bound by SCOTUS’ findings in Amgen v Sanofi.   21 September 2023
Pharma
Pfizer must hand over COVID-19 vaccine knowledge
Moderna alleges that rivals’ vaccine infringes patents filed covering a foundational mRNA technology | Big pharma firm must “specifically describe” awareness of Moderna's work in the mRNA vaccine sphere before the end of the month.   19 September 2023
Pharma
Regimen patents in Japan: LCM failures and successes
Examining a series of case studies, Takanori Abe of Abe & Partners provides an overview of lifecycle management failures and successes in regimen patents.   19 September 2023
Pharma
US Court of Appeals sides with Apple in Masimo dispute
Court upholds USPTO and the PTAB decisions over blood-oxygen sensor in smartwatches | Ruling finds Masimo patents to be unpatentable and obvious | Only one claim relating to inconsistency to be reversed.   14 September 2023
Pharma
Bausch Ireland fends off challenge to its cancer patent
Pharma firm fails to show evidence to prove obviousness in rival’s patent | Treatment can be used to treat cancer as well as ulcerative colitis and asthma.   12 September 2023